ADMA Biologics, Inc. (ADMA)

9.68 +0.13 (+1.36%) USD  |  NASDAQ  |  Aug 25, 13:19
More

ADMA Biologics EPS Estimates for Next Quarter

EPS Estimates for Next Quarter Chart

View EPS Estimates for Next Quarter for ADMA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Estimates for Next Quarter Chart
Start Trial

Historical EPS Estimates for Next Quarter Data

View and export this data back to 2024. Start Trial.
Date Value
August 06, 2026 --
July 15, 2026 --
June 15, 2026 --
June 10, 2026 --
May 07, 2026 --
May 04, 2026 --
April 20, 2026 --
April 13, 2026 --
February 26, 2026 --
January 09, 2026 --
December 17, 2025 --
December 12, 2025 --
November 06, 2025 --
August 07, 2025 --
July 22, 2025 --
June 04, 2025 --
May 16, 2025 --
Date Value
May 08, 2025 --
April 28, 2025 --
March 19, 2025 --
March 04, 2025 --
January 14, 2025 --
January 13, 2025 --
December 17, 2024 --
November 08, 2024 --
October 31, 2024 --
October 14, 2024 --
August 12, 2024 --
August 09, 2024 --
July 15, 2024 --
July 12, 2024 --
May 10, 2024 --
April 11, 2024 --

Earnings Per Share Estimates Definition

This is the earnings consensus estimate for a given period of time, according to analysts polled by Standard & Poor's.

Read full definition.

EPS Estimates for Next Quarter Range, Past 5 Years

View EPS Estimates for Next Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Estimates for Next Quarter Benchmarks

View EPS Estimates for Next Quarter Benchmarks
Start Trial
Erasca, Inc. Upgrade
Krystal Biotech, Inc. Upgrade
Vericel Corp. Upgrade
Emergent BioSolutions, Inc. Upgrade
Exelixis, Inc. Upgrade

EPS Estimates for Next Quarter Related Metrics

Revenue Estimates for Current Quarter Upgrade
Revenue Estimates for Next Quarter Upgrade
Revenue Estimates for Current Fiscal Year Upgrade
Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade